PACS Gene Family-Related Neurological Diseases: Limited Genotypes and Diverse Phenotypes

Han Zhang,Kai Gao,Shuang Wang,Yue-Hua Zhang,Zhi-Xian Yang,Ye Wu,Yu-Wu Jiang
DOI: https://doi.org/10.1007/s12519-022-00652-z
2024-01-01
World Journal of Pediatrics
Abstract:The PACS gene family has been demonstrated to be related to intracellular vesicular trafficking. The phenotypic manifestations caused by the pathogenic variants of PACS include epilepsy, intellectual disability/developmental delay, and malformations, such as facial abnormalities. We identified seven new cases with pathogenic or likely pathogenic PACS variants using next-generation sequencing. Detailed information obtained from these patients was analyzed along with that obtained from previously reported patients. With the inclusion of the newly diagnosed cases in this study, 103 cases with PACS gene family-related neurological diseases were reported, of which 43 were PACS2-related cases and the remaining were PACS1-related cases. Most patients had seizures, which have been reported to be effectively controlled by several types of anti-seizure medications (ASMs). The most efficacious and frequently prescribed ASMs included sodium valproate (43.3
What problem does this paper attempt to address?